In Vitro and In Vivo Drug Discovery Assays: Drug Metabolism and Pharmacokinetics Testing (2024-UWMSN-00604-RFB).

The University of Wisconsin-Madison is soliciting bids for comprehensive In Vitro and In Vivo Drug Discovery Assays, specifically focused on Drug Metabolism and Pharmacokinetics Testing. This procurement is identified by the event number 2024-UWMSN-00604-RFB and will be conducted through the ShopUW+ online bidding platform. Potential vendors must submit their complete responses electronically through the specified web portal by April 19, 2024. The procurement appears to require sophisticated scientific testing capabilities, likely targeting pharmaceutical research and development laboratories that can perform complex drug metabolism studies and pharmacokinetic assessments. Vendors will need to demonstrate advanced technical capabilities in biological testing methodologies, including both in vitro cellular and in vivo animal model testing protocols. All questions regarding the solicitation must be submitted directly to Carla Parker via email at carla.parker@wisc.edu, and bidders are expected to carefully review all specifications and requirements before submission.

While specific set-aside designations are not explicitly detailed in the provided documentation, the procurement appears to be open to qualified scientific research and testing laboratories with specialized capabilities in pharmaceutical research. The contract opportunity suggests a potential focus on advanced scientific service providers with expertise in drug discovery and metabolic testing frameworks. Given the specialized nature of the requested services, potential respondents will likely need extensive credentials in biochemical research, laboratory testing, and pharmaceutical development protocols. The procurement does not specify an exact award value or budget range, which indicates that pricing will be competitively determined through the bidding process. Vendors should anticipate providing comprehensive proposals that demonstrate technical expertise, methodological precision, and potential cost-effectiveness in delivering the required drug discovery and pharmacokinetic testing services.